Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
Introduction: The live-attenuated recombinant vesicular stomatitis virus vaccine expressing the glycoprotein (GP) of Zaire Ebola virus (rVSV-ZEBOV) has proven immunogenic in humans and effective in field studies. Yet long-term durability of vaccine responses is unknown. Areas covered: We survey the...
| Główni autorzy: | , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Taylor & Francis Group
2018-12-01
|
| Seria: | Expert Review of Vaccines |
| Hasła przedmiotowe: | |
| Dostęp online: | http://dx.doi.org/10.1080/14760584.2018.1546582 |